Virinder Nohria Net Worth & Insider Trades
Virinder Nohria - Director, Horizon Pharma Plc
What is Virinder Nohria's Net Worth?
The current estimated net worth of Horizon Pharma Plc's Director, Virinder Nohria, is estimated to be about $22.55M . Virinder Nohria owns about 195,094 units of Horizon Pharma Plc common stock. In the last 3 years at Horizon Pharma Plc, Virinder Nohria has sold an estimated value of $20.51M worth.
What is Virinder Nohria's Past Insider Trading?
Virinder Nohria's largest sale order was 1,739,130 units , worth over $20.07M on November 17, 2014. In total, Virinder Nohria has made about 7 transactions over 3 years of their time at Horizon Pharma Plc. Virinder Nohria usually trades in May, with the busiest year in 2016. The most recent transaction was a sale order of 25,000 units , worth over $442.28K on June 15, 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Virinder Nohria
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Virinder Nohria's' Mailing Address?
- Mailing address is 1055 Powers Place, Suite B Alpharetta GA 30009 GA
Horizon Pharma Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Timothy P. Walbert | 2020 | $1,146,542 | - | $199,548 | $199,548 | $199,548 | $199,548 | $21,632,803 |
| Timothy P. Walbert | 2019 | $1,108,700 | - | $226,871 | $226,871 | $226,871 | $226,871 | $13,873,172 |
| Timothy P. Walbert | 2018 | $1,076,250 | - | $160,363 | $160,363 | $160,363 | $160,363 | $16,796,894 |
| Paul W. Hoelscher | 2020 | $600,569 | - | $106,485 | $106,485 | $106,485 | $106,485 | $5,915,146 |
| Paul W. Hoelscher | 2019 | $580,748 | - | $120,135 | $120,135 | $120,135 | $120,135 | $4,443,588 |
| Paul W. Hoelscher | 2018 | $563,750 | - | $104,332 | $104,332 | $104,332 | $104,332 | $7,034,386 |
| Andy Pasternak | 2020 | $669,021 | $250,000 | $66,872 | $66,872 | $66,872 | $66,872 | $5,826,126 |
| Andy Pasternak | 2019 | $108,333 | $500,000 | $19,188 | $19,188 | $19,188 | $19,188 | $2,924,542 |
| Jeffrey W. Sherman, M.D., FACP | 2020 | $578,731 | - | $92,545 | $92,545 | $92,545 | $92,545 | $5,261,300 |
| Jeffrey W. Sherman, M.D., FACP | 2019 | $559,630 | - | $95,222 | $95,222 | $95,222 | $95,222 | $3,568,496 |
| Jeffrey W. Sherman, M.D., FACP | 2018 | $543,250 | - | $68,263 | $68,263 | $68,263 | $68,263 | $3,678,874 |
| Barry J. Moze | 2020 | $628,960 | - | $75,659 | $75,659 | $75,659 | $75,659 | $5,073,877 |
| Barry J. Moze | 2019 | $608,201 | - | $58,744 | $58,744 | $58,744 | $58,744 | $4,662,510 |
| Barry J. Moze | 2018 | $590,400 | - | $35,114 | $35,114 | $35,114 | $35,114 | $2,732,565 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm
What are Horizon Pharma Plc's Past Insider Trades?
Horizon Pharma Plc's most recent insider trade came on January 18, 2023 by Andy Pasternak who sold 27,129 units worth $3.07M . In the last 12 years, insiders at Horizon Pharma Plc have sold an estimated value of $967.93M and bought an estimated value of $122.97M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman, Jeffrey Sherman, EVP and Chief Medical Officer, and Paul Hoelscher, EVP .
Horizon Therapeutics Public Ltd Co Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||